INSIGHTS ON REGULATORY COMPLIANCE

• Digital Process Twin Cuts J&J Production Time And Costs

  Virtual process modeling is helping to cut production time, reduce solvent use, and improve sustainability. Learn how digital twins enable faster scale‑up decisions and more efficient manufacturing.

• Shedding Light On Photo-Stability Forced Degradation

  Ensure the stability and safety of your drug products by utilizing comprehensive forced degradation and photo-stability testing, guided by ICH and FDA standards, to identify degradation pathways and assess light exposure risks.

• Smarter By The Second Redefining Pharma Biopharma Manufacturing

  Continuous monitoring is transforming manufacturing. With advanced analytics and sensor technologies, teams can detect issues early and optimize processes in real time for greater efficiency.

• 6 Things To Consider During Visual Inspection Operations

  Even with automation, manual visual inspection remains vital in sterile drug manufacturing. Discover six advanced considerations for refining your operations, ensuring compliance, and minimizing costs.

• Equipment Life Cycle: It's A Commitment

  4/7/2026

  Progress depends on systems that grow with your work. Discover how end‑to‑end support keeps instruments running reliably, reduces long‑term risk, and ensures performance stays aligned with operations.

• Control Strategies And Method Development For Nitrosamines In Peptide APIs And Drug Products

  11/26/2024

  Pharmaceutical scientists and engineers must advance robust, sensitive, and efficient nitrosamine detection and control methods to ensure regulatory compliance and safeguard public health in peptide-based drugs.

• OEE And Product Inspection

  2/13/2025

  Explore the calculation of Overall Equipment Effectiveness (OEE) and the impact of product inspection equipment on OEE in the pharmaceutical industry.

• FDA's New Flexible CMC Framework For CGT

  4/14/2026

  The FDA is rethinking CMC oversight for cell and gene therapies, prioritizing science‑based justification over rigid validation models. Learn how this lifecycle‑focused approach could reduce burden.

• Transforming Development Through Mass Spectrometry Data Analysis

  1/29/2026

  Mass spectrometry is vital for understanding PTMs in modern biologics. Explore key challenges and how streamlined analysis can reveal deeper, more sensitive insights into biotherapeutic structure.